NCT07208721Not yet recruiting
The Key to Emotional Balance
The Key to Emotional Balance: The Effect of a Positive Psychotherapy-Based Balance Model on Emotion Regulation, Recovery, and Life Purpose in Bipolar Disorder
Source: ClinicalTrials.gov · Last updated 6 Oct 2025 · Not updated for over 12 months - ask the site whether it is still open
Brief summary (registry, in English)
This randomized controlled experimental study aimed to evaluate the effects of the Key to Emotional Balance (KBA) psychoeducational program, based on the Balance Model of Positive Psychotherapy (PPT), on indicators of emotion regulation difficulties, recovery, and purpose in life in adults with bipolar disorder. Intervention and control groups (n=37 each; total n=74) will be formed through simple random assignment. The intervention will consist of eight individual sessions, each lasting 40-50 minutes. Data will be collected using the Difficulty in Emotion Regulation, Recovery Assessment Scale, and the Life Goals Scale in the Context of PPT. Measurements will be conducted as a pretest and posttest.
- Status (registry)
- Not yet recruiting
- Study type
- Interventional
- Enrollment
- 74 (estimated)
- First submitted
- 28 Sept 2025
- Start date
- 1 Oct 2025
- Primary completion date
- 1 Jun 2026
- Lead sponsor
- TC Erciyes University
- Diseases
- Bipolar disorder
- NCT number
- NCT07208721
What you commit to
- Study type: Interventional
- Planned participants: 74
- From 1 Oct 2025 to the primary completion date, 1 Jun 2026
- No sites listed in no country
- Visits and tests: ask the trial team, the registry does not list them
Built from the registry fields of ClinicalTrials.gov. It describes the study, not your situation.
Who cannot take part
Copied verbatim from ClinicalTrials.gov and grouped by topic. Only the trial team decides who can take part.
Prior treatment
- Refusal to attend regular therapy sessions or severe resistance to psychotherapy.
Other illness
- Having a diagnosis of another serious psychiatric disorder such as schizophrenia, schizoaffective disorder, severe anxiety disorder, or obsessive-compulsive disorder (OCD).
- Cognitive impairments, such as dementia, severe cognitive impairment, or mental retardation, that would prevent participation in the recommended therapy.
- Individuals with a history of substance abuse within the last 6 months or ongoing active substance use.
- Individuals who are not compliant with recommended medication for bipolar disorder.
- Serious medical problems or chronic conditions that would prevent recommended psychotherapy (e.g., uncontrolled epilepsy or serious cardiovascular disease).
- Relapse of disease during the study and inability to comply with the program.
Other
- Being in an episode of acute mania or severe depression.
- Individuals who have attempted suicide within the last 6 months or who currently have suicidal thoughts (patients at high risk of suicide).
- Inability to speak Turkish sufficiently to understand the questionnaires and therapeutic interventions or difficulty communicating.
- Not attending psychoeducation sessions more than three times or not completing any of the pretest and posttest measures of the data collection forms.
- Participating in any other program while the study is ongoing.
Who the study is looking for
- Having a diagnosis of bipolar I or bipolar II disorder according to the DSM-5.
- Being between 18 and 65 years of age.
- Being literate and having the cognitive capacity to participate in written questionnaires.
- Being in a stable mood/remission (neither severely manic nor severely depressed) at the start of the study.
- Being on medication or willing and able to comply with treatment.
- Voluntarily agreeing to participate in the study and signing the informed consent form.
Age in the registry: 18 years to 65 years · Sex: All · Does not accept healthy volunteers
This page is information, not medical advice. Discuss any trial with your doctor.